K2 HealthVentures Equity Trust LLC 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:41 pm Purchase |
2022-10-25 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
K2 HealthVentures Equity Trust LLC | 10,524,401 7.800% |
10,524,401 (New Position) |
Filing |